Journal
FLUIDS AND BARRIERS OF THE CNS
Volume 14, Issue -, Pages -Publisher
BMC
DOI: 10.1186/s12987-017-0067-0
Keywords
Foetal-onset hydrocephalus; Blood-brain barrier; Cerebrospinal fluid; Cell therapy
Categories
Funding
- Fondef Ide [A14I10236]
- Fondecyt (Chile) [1111018]
Ask authors/readers for more resources
Despite decades of research, no compelling non-surgical therapies have been developed for foetal hydrocephalus. So far, most efforts have pointed to repairing disturbances in the cerebrospinal fluid (CSF) flow and to avoid further brain damage. There are no reports trying to prevent or diminish abnormalities in brain development which are inseparably associated with hydrocephalus. A key problem in the treatment of hydrocephalus is the blood-brain barrier that restricts the access to the brain for therapeutic compounds or systemically grafted cells. Recent investigations have started to open an avenue for the development of a cell therapy for foetal-onset hydrocephalus. Potential cells to be used for brain grafting include: (1) pluripotential neural stem cells; (2) mesenchymal stem cells; (3) genetically-engineered stem cells; (4) choroid plexus cells and (5) subcommissural organ cells. Expected outcomes are a proper microenvironment for the embryonic neurogenic niche and, consequent normal brain development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available